About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.69B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Generali Investments Towarzystwo Funduszy Inwestycyjnych Portfolio

Follow Generali Investments Towarzystwo Funduszy Inwestycyjnych and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Generali Investments Towarzystwo Funduszy Inwestycyjnych, based on Form 13F filings with the SEC.

News

Stay updated on Generali Investments Towarzystwo Funduszy Inwestycyjnych with notifications on news.